Company Ascendis Pharma A/S

Equities

ASND

US04351P1012

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:00 2024-07-12 pm EDT 5-day change 1st Jan Change
138.1 USD +1.75% Intraday chart for Ascendis Pharma A/S +1.67% +9.63%

Business Summary

Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).

Number of employees: 879

Sales per Business

USD in Million2022Weight2023Weight Delta
Pharmaceutical Products
100.0 %
54 100.0 % 288 100.0 % +436.15%

Sales per region

USD in Million2022Weight2023Weight Delta
North America
71.9 %
46 86.3 % 207 71.9 % +346.54%
Asia
27.8 %
7 12.6 % 80 27.8 % +1,080.01%
Europe
0.3 %
1 1.1 % 1 0.3 % +61.94%

Managers

Managers TitleAgeSince
Founder 65 06-08-31
Director of Finance/CFO 50 16-08-07
Chief Tech/Sci/R&D Officer 50 20-04-30
Chief Tech/Sci/R&D Officer 46 07-11-30
Chief Administrative Officer 62 07-11-30
Comptroller/Controller/Auditor 55 14-02-28
Corporate Officer/Principal 63 15-07-31
General Counsel 53 07-12-31

Members of the board

Members of the board TitleAgeSince
Founder 65 06-08-31
Chairman 51 14-10-31
General Counsel 53 07-12-31
Director/Board Member 56 17-03-31
Director/Board Member 66 18-11-01
Director/Board Member 60 22-08-31
Director/Board Member 47 22-08-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 59,106,149 6,000,000 ( 10.15 %) 881,730 ( 1.492 %) 10.15 %

Shareholders

NameEquities%Valuation
RA Capital Management LP
17.52 %
10,108,400 17.52 % 1 379 M $
Artisan Partners Holdings LP
9.829 %
5,671,934 9.829 % 774 M $
Fidelity Management & Research Co. LLC
8.558 %
4,938,461 8.558 % 674 M $
Westfield Capital Management Co. LP
7.062 %
4,075,214 7.062 % 556 M $
Avoro Capital Advisor LLC
6.874 %
3,966,666 6.874 % 541 M $
Janus Henderson Investors US LLC
6.528 %
3,767,203 6.528 % 514 M $
Wellington Trust Co., NA
4.758 %
2,745,872 4.758 % 374 M $
T. Rowe Price Investment Management, Inc.
4.452 %
2,568,903 4.452 % 350 M $
Capital Research & Management Co. (International Investors)
3.797 %
2,191,312 3.797 % 299 M $
Fiduciary Trust Company International
3.434 %
1,981,869 3.434 % 270 M $
NameEquities%Valuation
423,279 0.8903 % 58 M $
Scott Smith
0.008449 %
4,017 0.008449 % 547 838 $
2,888 0.006074 % 393 865 $
Stina Singel
0.005740 %
2,729 0.005740 % 372 181 $
1,931 0.004061 % 263 350 $
1,858 0.003908 % 253 394 $
1,858 0.003908 % 253 394 $
GF Fund Management Co., Ltd.
0.002303 %
1,095 0.002303 % 149 336 $
Lars Holtug
0.001876 %
892 0.001876 % 121 651 $
391 0.000822 % 53 325 $

Company contact information

Ascendis Pharma A/S

Tuborg Boulevard 12

2900, Hellerup

+45 70 22 22 44

http://www.ascendispharma.com
address Ascendis Pharma A/S(ASND)
  1. Stock Market
  2. Equities
  3. ASND Stock
  4. Company Ascendis Pharma A/S